Molecular epidemiology of JCV genotypes in patients and healthy subjects from Northern Italy

Journal of Medical Virology

Volumn 85, Issue 7, 2013, Pages 1286-1292

  Zanotta, Nunzia ^a   Delbue, Serena ^b   Rossi, Tatiana ^a   Pelos, Giorgio ^a   D'Agaro, Pierlanfranco ^a,c   Monasta, Lorenzo ^a   Ferrante, Pasquale ^d   Comar, Manola ^a,c  

^a INSTITUTE FOR MATERNAL AND CHILD HEALTH IRCCS BURLO GAROFOLO   (Italy)

^b Stem Wave Institute for Tissue Healing (SWITH)   (Italy)

^c UNIVERSITY OF TRIESTE   (Italy)

^d UNIVERSITY OF MILAN   (Italy)

Author keywords

Immunocompromised and healthy subjects; JCV; Subtypes

Indexed keywords

VIRUS PROTEIN;

ADOLESCENT; ADULT; AGED; ARTICLE; CAUCASIAN; CHILD; COLON CANCER; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; GENDER; GENOTYPE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNOCOMPROMISED PATIENT; INFLAMMATORY DISEASE; ITALY; JC VIRUS; MAJOR CLINICAL STUDY; MALE; MOLECULAR EPIDEMIOLOGY; MULTIPLE SCLEROSIS; PRESCHOOL CHILD; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; REAL TIME POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; URINALYSIS;

IMMUNOCOMPROMISED AND HEALTHY SUBJECTS; JCV; SUBTYPES;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; FEMALE; GENOTYPE; HUMANS; IMMUNOCOMPROMISED HOST; INFANT; INFANT, NEWBORN; ITALY; JC VIRUS; MALE; MIDDLE AGED; MOLECULAR EPIDEMIOLOGY; POLYOMAVIRUS INFECTIONS; PREVALENCE; REAL-TIME POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS, DNA; TUMOR VIRUS INFECTIONS; URINE; YOUNG ADULT;

EID: 84878216148     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.23585     Document Type: Article

References (44)

1. Agostini HT, Ryschkewitsch CF, Stoner GL. 1996. Genotype profile of human polyomavirus JC excreted in urine of immunocompetent individuals. J Clin Microbiol 34:159-164.
2. Agostini HT, Ryschkewitsch CF, Singer EJ, Stoner GL. 1997a. JC virus regulatory region rearrangements and genotypes in progressive multifocal leukoencephalopathy: Two independent aspects of virus variation. J Gen Virol 78:659-664.
3. Agostini HT, Ryschkewitsch CF, Mory R, Singer EJ, Stoner GL. 1997b. JC virus (JCV) genotypes in brain tissue from patients with progressive multifocal leukoencephalopathy (PML) and in urine from controls without PML: Increased frequency of JCV type 2 in PML. J Infect Dis 176:1-8.
4. Agostini HT, Ryschkewitsch CF, Singer EJ, Baumhefner RW, Stoner GL. 1998. JC virus type 2B is found more frequently in brain tissue of progressive multifocal leukoencephalopathy patients than in urine from controls. J Hum Virol 1:200-206.
5. Agostini HT, Ryschkewitsch CF, Baumhefner RW, Tourtellotte WW, Singer EJ, Komoly S, Stoner GL. 2000. Influence of JC virus coding region genotype on risk of multiple sclerosis and progressive multifocal leukoencephalopathy. Neurovirol 2:101-108.
6. Agostini HT, Deckhut A, Jobes DV, Girones R, Schlunck G, Prost MG, Frias C, Pérez-Trallero E, Ryschkewitsch CF, Stoner GL. 2001. Genotypes of JC virus in East, Central and Southwest Europe. J Gen Virol 82:1221-1331.
7. Ault GS, Stoner GL. 1992. Two major types of JC virus defined in progressive multifocal leukoencephalopathy brain by early and late coding region DNA sequences. J Gen Virol 73:2669-2678.
8. Ault GS, Stoner GL. 1993. Human polyomavirus JC promoter/enhancer rearrangement patterns from progressive multifocal leukoencephalopathy brain are unique derivatives of a single archetypal structure. J Gen Virol 74:1499-1507.
9. Berger JR. 2010. Progressive multifocal leukoencephalopathy and never biological agents. Drug Saf 33:969-983.
10. Chesters PM, Heritage J, McCance DJ. 1983. Persistence of DNA sequences of BK virus and JC virus in normal human tissues and in diseased tissues. J Infect Dis 147:676-684.
11. Clifford DB, De Luca A, Simpson DM, Arendt G, Giovannoni G, Nath A. 2010. Natalizumab-associated progressive multifocal leukoencephalopathy in patients with multiple sclerosis: Lessons from 28 cases. Lancet Neurol 9:438-446.
12. Comar M, Zanotta N, Croci E, Murru I, Marci R, Pancaldi C, Dolcet O, Luppi S, Martinelli M, Giolo E, Ricci G, Tognon M. 2012. Association between the JC polyomavirus infection and male infertilità. PLoS ONE 7:e42880.
13. Cubitt CL, Cui X, Agostini HT, Nerurkar VR, Scheirich I, Yanagihara R, Ryschkewitsch CF, Stoner GL. 2001. Predicted amino acid sequences for 100 JCV strains. J Neurovirol 7:339-344.
14. Cui X, Wang JC, Deckhut A, Joseph Eberwein P, Cubitt CL, Rysckewitsch CF, Agostini HT, Stoner GL. 2004. Chinese strains (Type 7) of JC virus are afro-asiatic in origin but are phylogenetically distinct from the Mongolian and Indian strains (Type 2D) and the Korean and Japanese strains (Type 2A). J Mol Evol 58:568-583.
15. Delbue S, Pagani E, Guerini FR, Agliardi C, Mancuso R, Borghi E, Rossi F, Boldorini R, Veggiani C, Car PG, Ferrante P. 2005. Distribution, characterization and significance of polyomavirus genomic sequences in tumors of the brain and its covering. J Med Virol 3:447-454.
16. Doerries K. 2006. Human polyomavirus JC and BK persistent infection. Adv Exp Med Biol 577:102-116.
17. Dubois V, Moret H, Lafon ME, Brodard V, Icart J, Ruffault A, Guist'hau O, Buffet-Janvresse C, Abbed K, Dussaix E, Ingrand D. 2001. JC virus genotypes in France: Molecular epidemiology and potential significance for progressive multifocal leukoencephalopathy. J Infect Dis 183:213-217.
18. Egli A, Infanti L, Dumoulin A, Buser A, Samaridis J, Stebler C, Gosert R, Hirsch HH. 2009. Prevalence of polyomavirus BK and JC infection and replication in 400 healthy blood donors. J Infect Dis 199:837-846.
19. Elsner C, Doerries K. 1998. Human polyomavirus JC control region variants in persistenly infected CNS and kidney tissue. J Gen Virol 79:789-799.
20. Ferenczy MW, Marshall LJ, Nelson CD, Atwood WJ, Nath A, Khalili K, Major EO. 2012. Molecular biology, epidemiology, and pathogenesis of progressive multifocal leukoencephalopathy, the JC virus-induced demyelinating disease of the human brain. Clin Microbiol Rev 3:471-506.
21. Gorelik L, Lerner M, Bixler S, Crossman M, Schlain B, Simon K, Pace A, Cheung A, Chen LL, Berman M, Zein F, Wilson E, Yednock T, Sandrock A, Goelz SE, Subramanyam M. 2010. Anti-JC virus antibodies: Implications for PML risk stratification. Ann Neurol 68:295-303.
22. Iida T, Kitamura T, Guo J, Taguchi F, Aso Y, Nagashima K, Yogo Y. 1993. Origin of JC polyomavirus variants associated with progressive multifocal leukoencephalopathy. Proc Natl Acad Sci USA 90:5062-5065.
23. Jensen PN, Major EO. 2001. A classification scheme for human polyomavirus JCV variants based on the nucleotide sequence of the noncoding regulatory region. J Neurovirol 27:280-287.
24. Kean JM, Rao S, Wang M, Garcea RL. 2009. Seroepidemiology of human polyomaviruses. PLoS Pathog 5:e1000363.
25. Kleinschmidt-DeMasters BK, Tyler KL. 2005. Progressive multifocal leukoencephalopathy complicating treatment with natalizumab and interferon beta-1a for multiple sclerosis. N Engl J Med 353:369-374.
26. Knowles WA. 2006. Discovery and epidemiology of the human polyomaviruses BK virus (BKV) and JC virus (JCV). Med Biol 577:19-45.
27. Langer-Gould A, Atlas SW, Green AJ, Bollen AW, Pelletier D. 2005. Progressive multifocal leukoencephalopathy in a patient treated with natalizumab. N Engl J Med 353:375-381.
28. Linda H, Von Heijne A, Major EO, Ryschkewitsch C, Berg J, Olsson T, Martin C. 2009. Progressive multifocal leukoencephalopathy after natalizumab monotherapy. N Engl J Med 361:1081-1087.
29. Liptai Z, Papp E, Barsi P, Mihály I, Szalai E, Csomor J, Jelenik Z. 2007. Progressive multifocal leukoencephalopathy in an HIV-infected child. Neuropediatrics 38:32-35.
30. Major EO. 2010. Progressive multifocal leukoencephalopathy in patients on immunomodulatory therapies. Annu Rev Med 61:35-47.
31. Pacifici M, Delbue S, Ferrante P, Jeansonne D, Kadri F, Nelson S, Velasco-Gonzalez C, Zabaleta J, Peruzzi F. 2013. Cerebrospinal fluid miRNA profile in HIV-encephalitis. J Cell Physiol 228:1070-1075.
32. Pagani E, Delbue S, Mancuso R, Borghi E, Tarantini L, Ferrante P. 2003. Molecular analysis of JC virus genotypes circulating among the Italian healthy population. J Neurovirol 9:559-566.
33. Pavesi A. 2003. African origin of polyomavirus JC and implications for prehistoric human migrations. J Mol Evol 56:564-572.
34. Raj GV, Khalili K. 1995. Transcriptional regulation: Lessons from the human neurotropic polyomavirus, JCV. Virology 213:283-291.
35. Reid CE, Li H, Sur G, Carmillo P, Bushnell S, Tizard R, McAuliffe M, Tonkin C, Simon K, Goelz S, Cinque P, Gorelik L, Carulli JP. 2011. Sequencing and analysis of JC virus DNA from natalizumab-treated PML patients. J Infect Dis 204:237-244.
36. Stoner GL, Jobes DV, Fernandez Cobo M, Agostini HT, Chima SC, Ryschkewitsch CF. 2000. JC virus as a marker of human migration to the Americas. Microbes Infect 2:1905-1911.
37. Tan CS, Chen Y, Viscidi RP, Kinkel RP, Stein MC, Koralnik IJ. 2010. Discrepant findings in immune responses to JC virus in patients receiving natalizumab. Lancet Neurol 9:565-566.
38. Tornatore C, Berger JR, Houff SA, Curfman B, Meyers K, Winfield D, Major EO. 1992. Detection of JC virus DNA in peripheral lymphocytes from patients with and without progressive multifocal leukoencephalopathy. Ann Neurol 31:454-462.
39. Trowbridge PW, Frisque RJ. 1995. Identification of three new JC virus proteins generated by alternative splicing of the early viral mRNA. J Neurovirol 2:195-206.
40. Van Assche G, Vermeire S, Rutgeerts P. 2005. Medical treatment of inflammatory bowel diseases. Curr Opin Gastroenterol 21:443-447.
41. Vaz B, Cinque P, Pickhardt M, Weber T. 2000. Analysis of the transcriptional control region in progressive multifocal leukoencephalopathy. J Neurovirol 6:398-409.
42. Viscidi RP, Khanna N, Tan CS, Li X, Jacobson L, Clifford DB, Nath A, Margolick JB, Shah KV, Hirsch HH, Koralnik IJ. 2011. JC virus antibody and viremia as predictors of progressive multifocal leukoencephalopathy in human immunodeficiency virus-1-infected individuals. Clin Infect Dis 53:711-715.
43. Yanagihara R, Nerurkar VR, Scheirich I, Agostini HT, Mgone CS, Cui X, Jobes DV, Cubitt CL, Ryschkewitsch CF, Hrdy DB, Friedlaender JS, Stoner GL. 2002. JC virus genotypes in the western Pacific suggest Asian mainland relationships and virus association with early population movements. Hum Biol 74:473-488.
44. Yogo Y, Kitamura T, Sugimoto C, Ueki T, Aso Y, Hara K, Taguchi F. 1990. Isolation of a possible archetypal JC virus DNA sequence from non immunocompromised individuals. J Virol 64:3139-3143.